Benzinga's Top #PreMarket Gainers

gained 65.66 percent to $3.28 in pre-market trading as the company reported that its customer's TiGenix Phase 3 clinical trial has met primary endpoint.

shares jumped 22.58 percent to $4.18 in pre-market trading as the company reported additional data from VTI-208 presentation at the Rostock Conference.

shares rose 19.65 percent to $40.25 in pre-market trading following the announcement of positive ALN-PCSsc study results.

shares climbed 6.21 percent to $10.94 in pre-market trading. Analysts at JP Morgan initiated coverage of SunEdison with a Overweight rating.

shares rose 2.68 percent to $9.18 in pre-market trading. Deutsche Bank upgraded JC Penney from Hold to Buy and raised the price target from $10.00 to $12.00.